Omeros | Passivo Circulante





Passivo Circulante Alterar Data
Adma Biologics USD 56.49M 18.45M 2025-09
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Cytokinetics USD 142.14M 11.08M 2025-09
Dynavax Technologies USD 106.84M 11.39M 2025-09
Gilead Sciences USD 12.3B 1.11B 2025-09
Heron Therapeutics USD 89.71M 168.89M 2025-09
Immunic USD 30.08M 2.77M 2025-09
Insmed USD 417.21M 105.53M 2025-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
MacroGenics USD 44.47M 5.47M 2025-09
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 107.08M 206.09M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Rockwell Medical USD 10.95M 259K 2025-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
United Therapeutics USD 546.3M 19.2M 2025-09
Vertex Pharmaceuticals USD 4.48B 336.9M 2025-09
Xoma USD 28.3M 6.81M 2025-09


Omeros Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.